PetIQ Inc

PetIQ Inc(PETQ)股票分析

$30.990

0.000 (0.00%)收盤時

Loading chart…
最高
30.990
開盤
30.990
成交量加權均價
—
成交量
0.00
市值
654.17M
最低
30.990
成交金額
0.00
企業價值/稅息折舊攤銷前利潤(TTM)
10.35

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The Company has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. It offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks.

petiq.com

分析師評級(5)

買進
4 買進
1 持有
0 賣出
目前: 30.99
最低
—
平均
—
最高
—

Truist Securities

2024-08-08

目標價

$31

持有

Benchmark

2024-05-10

目標價

$30

強烈買進

Jefferies

2024-03-19

目標價

$28

強烈買進

Jefferies

2023-12-19

目標價

$22

強烈買進

Truist Securities

2023-10-02

目標價

$30

強烈買進

估值指標

PetIQ Inc(PETQ)目前預期本益比為 17.77,5 年平均預期本益比為 15.03。

預期本益比

合理
5 年均值 P/E
15.03
目前P/E
17.77
高估
19.33
低估
10.74

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
9.01
目前EV/EBITDA
10.35
高估
10.44
低估
7.57

預期股價營收比

高估
5 年均值 P/S
0.49
目前P/S
0.75
高估
0.63
低估
0.34

PETQ 常見問題 —— 由 Alphio AI 解答

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The Company has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. It offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).

5 analysts cover PETQ: 4 rate it Buy, 1 Hold and 0 Sell.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易